Review
Copyright ©The Author(s) 2015.
World J Pharmacol. Jun 9, 2015; 4(2): 180-192
Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.180
Table 2 Phase III trials with targeted treatment in metastatic pancreatic cancer
Date publishedRegimenRef.Sample size (n)Median OS (mo)P value
2001Gem vs Gem + 5FUBerlin et al[103]3225.40.09
6.7
2004Gem vs Gem + IrinotecanRocha Lima et al[104]3606.60.789
6.3
2005Gem vs GemOxLouvet et al[105]3267.10.13
9.0
2007Gem vs Gem + capeHerrmann et al[106]3197.20.234
8.4
2006Gem vs Gem + IrinotecanStathopoulos et al[107]1456.40.970
6.5
2006Gem vs Gem + CisplatinHeinemann et al[108]1956.00.15
7.5